BioWorld

May 7, 2003

Testing Primates' Visual Response Against Flagging GABA In Cerebral Cortex Reveals New Drug Resource

Neurogenetics Licenses Rights To Pain Compound From Lilly

Incyte Reports Falling Revenue; Splits Discovery, Information Units

Other News To Note

SARS: Revenue Generator Or Flash-In-The-Pan Illness?

Biotechnology oftentimes eases into the wake of U.S. - and global - burgeoning health risks. That wake occasionally allows companies to ride the waves of newfound investor interest. (BioWorld Today) Read More

European Sector Experiences Falloff In Revenues, Employees

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

Illustration of glucose in the blood stream

CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

BioWorld Science

Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...

Saniona reports preclinical data for SAN-2668

BioWorld Science

Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...

CC-3 antibody shows antitumoral activity in penile cancer

BioWorld Science

Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...